trans-1,4-Dibromo-2-butene CAS 821-06-7 Purity ≥99.0% (GC) Ifektri Ikhwalithi Ephezulu
Umkhiqizi onekhwalithi ephezulu kanye nenani elincintisanayo
Izinsiza Ezihlobene Nezentengiso ze-Aliskiren:
I-Aliskiren CAS: 173334-57-1
I-Aliskiren Hemifumarate CAS: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
trans-1,4-Dibromo-2-Butene CAS: 821-06-7
I-Isovaleryl Chloride CAS: 108-12-3
I-D-Phenylalanine CAS: 673-06-3
I-D-Phenylalaninol CAS: 5267-64-1
| Igama Lekhemikhali | trans-1,4-Dibromo-2-Butene |
| Omqondofana | (E)-1,4-Dibromobut-2-ene;(2E)-1,4-Dibromo-2-butene |
| Inombolo ye-CAS | 821-06-7 |
| Inombolo yeCAT | I-RF-PI149 |
| Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
| I-Molecular Formula | I-C4H6Br2 |
| Isisindo samangqamuzana | 213.9 |
| I-Solubility ku-Methanol | Cishe Ukungafihli |
| Ibhrendi | I-Ruifu Chemical |
| Into | Imininingwane |
| Ukubukeka | Okuqinile Okumhlophe kuya Kunsundu |
| Ukuhlanzeka / Indlela Yokuhlaziya | ≥99.0% (GC) |
| Cis-Okuqukethwe | ≤0.20% |
| I-Melting Point | 50.0℃~54.0℃ |
| I-Tetrabromobutane (TBB) | ≤0.50% |
| Umswakama (KF) | ≤0.20% |
| Izinga Lokuhlola | I-Enterprise Standard |
| Ukusetshenziswa | Aliskiren (CAS 173334-57-1), Aliskiren Hemifumarate (CAS 173334-58-2) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo kanye nabaphakeli be-trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) enekhwalithi ephezulu, esetshenziswa kabanzi ekuhlanganiseni kwe-organic, ukuhlanganiswa kwemithi ephakathi nendawo i-active pharmaceutical ingredient (API) synthesis.
I-trans-1,4-Dibromo-2-Butene (i-CAS: 821-06-7) iyisihluthulelo esimaphakathi ekuhlanganiseni kwe-Aliskiren (CAS: 173334-57-1), i-API.I-Aliskiren iyisidakamizwa se-antihypertensive sesigaba sokuqala esisebenza ngokuvinjwa okuqondile kwe-renin.Kuboniswa ukusetshenziswa ngomlomo njenge-monotherapy noma ngokuhlanganiswa namanye ama-antihypertensive agents.Ukuvinjwa kwe-renin nge-aliskiren kuphumela ekwehleni kwamazinga e-angiotensin I, i-angiotensin II, ne-aldosterone, konke okunomthelela kumphumela we-antihypertensive.
